Each scientific advance in the fight against multiple sclerosis means further hope for patients and their families.
The recent designation by the FDD of tolebrutinib as a “breakthrough therapy” for multiple sclerosis is a new source of hope for the secondary progressive forms of the disease.
By targeting both innate and adaptive immunity, this treatment opens up new therapeutic possibilities and may well transform patient care in the future.
Manon, who lives with MS, will once again take part in the race with her team.
For the occasion, she has launched a delightful initiative: the Charcookies!
Homemade cookies, sold at €5 per bag to support the Foundation.
A big thank you to her — and to everyone who turns hope into action!
Reserve yours here: https://cookies.sclerose.be
This year, 137 dedicated runners will take on the challenge of the 20 km of Brussels in support of the Charcot Foundation.
A record number of participants… and a wonderful boost for multiple sclerosis research!
You can cheer them on by making a donation or sponsoring a runner:
https://support.sclerose.be/en-GB/projects
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
